Data contradict Swiss drug major's claim that India does not respect IPR.
The Indian Army on Thursday said it has registered the intellectual property rights of its new design and camouflage pattern uniform.
Leading auto maker Bajaj Auto on Monday said its technology ExhausTEC, which help improve performance of a two-wheeler, has been granted a patent by the Munich-headquartered European Patent Office.
Absence of operational manual that guides examiners, heavy backlog take a toll.
Underscoring the 'presumption of genuineness' of Aadhaar and voter ID, the Supreme Court on Monday refused to stay the publication of draft electoral rolls in poll-bound Bihar and said it would once and for all decide pleas against Election Commission's special intensive revision (SIR) of electoral rolls.
A bench of Justices Surya Kant and Joymalya Bagchi is likely to take up the matter in which the EC has justified its ongoing SIR of electoral rolls in Bihar, saying it adds to the purity of the election by "weeding out ineligible persons" from the electoral rolls.
358 of 413 drug patent applications for the disease in India are from top multinationals. An analysis of pharma patent applications pending with the patent office by the group, which did not wish to be identified, has put the number of cancer drug patent applications at 413. Of these, 358 came from top multinationals like Novartis, Aventis, Bristol Myers Squibb, Pfizer, Boehringer, Roche and Abbot.
Even as India is fast turning into the diabetes capital of the world, multinational drug companies are busy patenting new-generation diabetes medicines for exclusive marketing rights in the country.
In 2004, the patent office in India received around 20,000 patent filings, which included resident and non-resident patent applications, according to a report released by the World Intellectual Property Organisation.
The patent office said Pfizer's claimed patent for Sutent, a cancer drug, did not involve any inventive step.
The Supreme Court on Monday directed uniform pension benefits for all retired high court judges, irrespective of their mode of appointment or tenure, saying "one rank one pension has to be the norm in respect of a constitutional office".
'They wanted the city to be a great business hub. They didn't like the fact that taxes collected in Bombay would go outside the city.'
If the 'Captain Cool' trademark goes through, it could trigger a wave of similar attempts by celebrities to trademark nicknames given to them by fans.
US-based independent IT management software company CA Inc's India Technology Centre (ITC) at Hyderabad is in the process of filing 12 patents with the US Patent Office, said Lokesh Jindal, outgoing senior vice-president of the centre.
Individual scientists attached to research institutions and domestic companies like Lupin, Dr Reddy's and Cadila account for the rest.
Japan granted the maximum number of patents in 2007 and has replaced the United States from number one position, a status it was enjoying for nearly a decade, a UN agency report says.
The European Patent Office has upheld the revocation of a patent on the Indian 'neem' tree, dealing a killer blow to biopiracy in Europe and around the world.\n\n
The Indian Patent Office has granted the company its 'SNS' invention with patent no. 234044 on May 1, 2009, the company said. Bajaj Auto has applied for patent in several countries for this unique technology and is taking necessary steps to counter the menace of Chinese manufacturers unscrupulously marketing cheap copies of the technology in Nigeria (as 'NeXus' brand motorcycle) and in Kenya and Uganda (as 'Nebula' brand motorcycle), the statement added.
Although the revocation application was filed in August, it takes time for the Apellate Board to send notices and hence, TVS took upon itself to inform BAL about the same.
The Central Administrative Tribunal (CAT) has overturned the transfer of Indian Revenue Service (IRS) officer Sameer Wankhede from Mumbai to Chennai, ruling that the revenue department violated its own guidelines. Wankhede, known for his role in the Cordelia cruise drug bust case involving Bollywood actor Shah Rukh Khan's son, had claimed his transfer was punitive and a consequence of his actions at the Narcotics Control Bureau (NCB). The CAT found procedural lapses and potential bias in the transfer decision, stating that transfer policies must be implemented fairly and transparently.
First time, an Indian court revisits a patent office order.
Indian companies need not just make in India, but invent in India too
The European Patent Office (EPO) has rejected 15 patent applications of various international companies during the past one year after it found they had used India's traditional medicinal knowledge to prepare certain products.
Bayer will not accept a ruling by the Intellectual Property Appellate Board in Chennai on Monday, upholding the compulsory licence granted on March 9 last year and it will appeal against the patent office order at the high court in Mumbai, a spokesperson told PTI.
Mumbai-based Sun Pharmaceuticals has filed a post-grant opposition with the Mumbai patent office against a product patent granted to the extended release version of Johnson and Johnson's (J&J) blockbuster drug Risperdal, used in the treatment of psychological disorders and schizophrenia.
India has rejected a drug patent application of a United States multinational pharma company, paving the way for easy access to an important life-saving medication for HIV patients across the globe.
Minister of Science & Technology and Earth Sciences Prithviraj Chavan says in an exclusive interview that India has digitized all traditional knowledge of medicine available in India and has shared it with the US President and United States patents office so that nobody benefits unduly by using Indian knowledge and files for patents on such products.
The Prime Minister's Office (PMO) has sought the opinion of various stakeholder departments on the need for further amendments to the patent law to introduce some of the controversial provisions that were kept out during the previous amendment to the Indian Patent Act five years ago.
'We recently launched Yesintek in the immunology space.'
Patent filings in India would be more and more driven by new technologies, which are either kept secret or patented.
The United Kingdom extracted USD 64.82 trillion from India over a century of colonialism between 1765 and 1900 and USD 33.8 trillion of this went to the richest 10 per cent -- enough money to carpet London in notes of 50 British pound almost four times over.
The knife fragment that got lodged near the spine of actor Saif Ali Khan during the attack on him at his Bandra home as well as a part found at the scene of crime have matched with the weapon recovered from accused Mohammad Shariful Islam, police told a Mumbai court on Friday.
The rules, the first ever for software applications in the country, were recently issued by the patent office and mandate each new software to be 'machine-specific' and packaged with 'new hardware' to qualify for a licence.
The Union government on Friday made it clear before the Supreme Court that it is not contemplating filing objections before the European Patent Office to question grant of patent on a variety of wheat to the Monsanto.
Kamal has a crisp pen when it comes to writing short and yet powerful film dialogues. But while speaking ex tempore -- and that has been his style -- he looks every bit a confused man, observes N Sathiya Moorthy.
Multinational organizations including PepsiCo and industry associations like IPA, have come in favour of India's intellectual property regime, which is being reviewed by the US administration.
I'...additional concessions, such as opening government procurement, reducing agricultural subsidies, weakening patent protections, and allowing unrestricted data flows -- demands India has resisted for decades.'
'We don't have to compete with Maharashtra or Gujarat. We have to now start thinking about how we compete with the United States or China.'
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances